Ramipril

Ramipril is a pharmaceutical-grade active ingredient classified as an ACE Inhibitor Antihypertensive. Mediocon Inc supplies high-purity Ramipril API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Ramipril is a prodrug ACE inhibitor converted in vivo to ramiprilat, its active metabolite. It is used in the treatment of hypertension, heart failure, diabetic nephropathy, and for the prevention of myocardial infarction, stroke, and cardiovascular death in high-risk patients. Ramipril has demonstrated significant cardiovascular protective effects in major clinical trials.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Hypertension (including high-risk patients)
• Heart failure post-myocardial infarction
• Cardiovascular risk reduction (HOPE trial population)
• Diabetic and non-diabetic nephropathy

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings